Ropivacaine

Generic Name
Ropivacaine
Brand Names
Naropin
Drug Type
Small Molecule
Chemical Formula
C17H26N2O
CAS Number
84057-95-4
Unique Ingredient Identifier
7IO5LYA57N
Background

Ropivacaine is an aminoamide local anesthetic drug marketed by AstraZeneca under the trade name Naropin. It exists as a racemate of its S- and R-enantiomers, although the marketed form is supplied only as the purified S-enantiomer.

Indication

Ropivacaine is indicated in adult patients for the induction of regional or local anesthesia for surgery or acute pain management.

Associated Conditions
Acute Pain, Postoperative pain
Associated Therapies
Surgical anesthesia therapy

Ropivacaine Use in Femoral Nerve Block; What is the Minimal Effective Analgesic Concentration (MEAC 90)

Phase 4
Conditions
First Posted Date
2021-04-08
Last Posted Date
2021-04-08
Lead Sponsor
Healthpoint Hospital
Target Recruit Count
45
Registration Number
NCT04834440
Locations
🇦🇪

Healthpoint Hospital, Abu Dhabi, United Arab Emirates

Ropivacaine Use in Interscalene Block; What is the Minimal Effective Analgesic Concentration (MEAC 90)

Phase 4
Conditions
First Posted Date
2021-04-06
Last Posted Date
2021-04-06
Lead Sponsor
Healthpoint Hospital
Target Recruit Count
45
Registration Number
NCT04833296
Locations
🇦🇪

Healthpoint Hospital, Abu Dhabi, United Arab Emirates

Regional Anesthesia and Partial Mastectomy

First Posted Date
2021-04-01
Last Posted Date
2023-09-07
Lead Sponsor
Karlstad Central Hospital
Target Recruit Count
60
Registration Number
NCT04824599
Locations
🇸🇪

Central Hospital in Karlstad, Karlstad, Värmland, Sweden

Ropivacaine Pharmacokinetics in ESP Blocks

First Posted Date
2021-03-19
Last Posted Date
2022-06-06
Lead Sponsor
Thomas Jefferson University
Target Recruit Count
20
Registration Number
NCT04807504
Locations
🇺🇸

Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

Transversus Abdominis Plane Catheter Following Kidney Transplantation

First Posted Date
2021-03-08
Last Posted Date
2021-03-08
Lead Sponsor
Western University, Canada
Target Recruit Count
120
Registration Number
NCT04786470

Comparative Study Between Levobupivacaine and Ropivacaine in the Hip Fractures of the Elderly

Phase 4
Completed
Conditions
Interventions
First Posted Date
2021-02-26
Last Posted Date
2024-07-19
Lead Sponsor
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Target Recruit Count
114
Registration Number
NCT04773301
Locations
🇪🇸

Complejo Asistencial Universitario de Salamanca, Salamanca, Spain

The Significance of Peripheral Input

Not Applicable
Conditions
Interventions
First Posted Date
2021-02-21
Last Posted Date
2021-02-21
Lead Sponsor
Bispebjerg Hospital
Target Recruit Count
12
Registration Number
NCT04764045
Locations
🇩🇰

Bispebjerg Hospital, Copenhagen, Denmark

The Optimal Dosage of Ropivacaine for Arthroscopic Knee Surgery

First Posted Date
2021-02-18
Last Posted Date
2023-08-15
Lead Sponsor
Yanchao Yang
Target Recruit Count
115
Registration Number
NCT04759742
Locations
🇨🇳

Shengjing Hospital, Shengyang, Liaoning, China

Erector Spinae Plane Block With Ropivacaine for Major Upper Abdominal Surgery

First Posted Date
2021-01-11
Last Posted Date
2021-01-11
Lead Sponsor
Nazarbayev University Medical Center
Target Recruit Count
50
Registration Number
NCT04702685
Locations
🇰🇿

National Center for Oncology, Astana, Kazakhstan

Regional Anesthesia in Pediatric Orthopaedic Patients

First Posted Date
2020-12-16
Last Posted Date
2023-04-24
Lead Sponsor
Ochsner Health System
Target Recruit Count
88
Registration Number
NCT04669145
Locations
🇺🇸

Ochsner Medical Center, Jefferson, Louisiana, United States

© Copyright 2024. All Rights Reserved by MedPath